[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-361130-105":59,"doc-detail-361130-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","mit-fusions-tsc1-tsc2-divergence-and-stem-like-programs-reveal-distinct-originsand-vulnerabilities-in-pecoma-article","MiT fusions, TSC1-TSC2 divergence, and stem-like programs reveal distinct originsand vulnerabilities in PEComa - Article","","Perivascular epithelioid cell neoplasms (PEComas) are ultra-rare mesenchymal tumors without a molecular classification to guide therapy. Comprehensive multi-omic profiling of an unselected cohort identifies frequent MITF rearrangements with actin gene partners and reveals anatomical patterns in kinase module and mTOR alterations. Transcriptomics defines four subtypes with distinct lineage programs, including an aggressive stem-like subtype enriched for TP53/RB1 mutations, high proliferation, embryonic and Hedgehog signaling, immune infiltration, and resistance to mTOR inhibitors with potential immunotherapy responsiveness. Single-nucleus RNA sequencing shows intratumoral heterogeneity within this subtype, including divergent inflammatory states, enabling actionable vulnerability discovery.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/mit-fusions-tsc1-tsc2-divergence-and-stem-like-programs-reveal-distinct-originsand-vulnerabilities-in-pecoma-article/361130/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/mit-fusions-tsc1-tsc2-divergence-and-stem-like-programs-reveal-distinct-originsand-vulnerabilities-in-pecoma-article/361130.png","ImageObject",300,407,{"name":92,"@type":93},"kopisore","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What molecular alterations are frequently observed involving MITF in PEComa?","Question",{"text":112,"@type":113},"The study identifies frequent MITF rearrangements involving actin gene partners such as ACTA2, ACTG1, and ACTB.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do tumor subtypes and lineage programs relate to PEComa behavior?",{"text":117,"@type":113},"Transcriptomic analysis defines four subtypes with distinct lineage programs (melanocytic, mesenchymal, adipogenic), each with unique mutational patterns and clinical behaviors.",{"name":119,"@type":110,"acceptedAnswer":120},"What characterizes the aggressive stem-like subtype and its treatment implications?",{"text":121,"@type":113},"The aggressive stem-like subtype is enriched for TP53/RB1 mutations, shows high proliferation and embryonic/Hedgehog activation, immune infiltration, and resistance to mTOR inhibitors, with potential responsiveness to immunotherapy.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},361130,1790211127,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":26,"preview_page_count":19,"preview_urls":145},962090880963,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Article [https://doi.org/10.1038/s41467-026-74545-4](https://doi.org/10.1038/s41467-026-74545-4)  \nMiT fusions, TSC1–TSC2 divergence, and stem-like programs reveal distinct originsand vulnerabilities in PEComa  \nReceived: 28 May 2025  \n\n| Accepted: 5 June 2026 |\n| --- |\n| |\n| Check for updates |\n\nJustine Gantzer 1,2,28 , Xiaofan Lu 1,28, Céline Charon-Barra3,  \nCharles Vinson3, Noëlle Weingertner4, Antonin Fattori1,4, Marie-Pierre Chenard4, Damien Plassard 5, Serge Vicaire5, François Le Loarer 6, Maud Toulmonde7, Marie Karanian8, Mehdi Brahmi9, Carine Ngo10, Axel Le Cesne11, Alice Hervieu12, Lenaïg Mescam-Mancini13, François Bertucci 14, Juliette Beaujot15,  \nThomas Ryckewaert16, Philippe Rochaix 17, Thibaud Valentin18,  \nNicolas Macagno19, Florence Duffaud20, Matthias Tallegas 21, Bruno Chetaille22, Isabelle Valo23, Emmanuelle Bompas24, Marick Lae25, Flore Delalande26, Francisco Llamas-Gutierrez27, Nathalie Rioux-Leclercq27, Jean-Yves Blay 9, Jean-Emmanuel Kurtz1,2 & Gabriel G. Malouf 1,2   \nPerivascular epithelioid cell neoplasms (PEComas) are ultra-rare mesenchymal tumors lacking a molecular classiﬁcation to guide therapy. Here we perform comprehensive multi-omic proﬁling of an unselected PEComa cohort. We identify frequent MITF rearrangements involving actin gene partners (ACTA2, ACTG1 and ACTB). Anatomical stratiﬁcation reveals cyclin-dependent kinase module mutations in gynecologic tumors, whereas soft tissue, gastrointestinal, and pelvic tumors lacked mTOR pathway alterations but are enriched for TFE3/MITF rearrangements. Transcriptomic analysis deﬁnes four subtypes with distinct lineage programs—melanocytic, mesenchymal, or adipogenic—as well as unique mutational patterns and clinical behaviors. Notably, an aggressive stem-like subtype enriched for TP53/RB1 mutations exhibits high proliferation, activation of embryonic and Hedgehog signaling, immune inﬁltration, and resistance to mTOR inhibitors, but potential responsiveness to immunotherapy. Single-nucleus RNA sequencing reveals intra-tumoral heterogeneity within this subtype, including divergent inﬂammatory states. Together, these ﬁndings establish a molecular classiﬁcation framework and identify actionable vulnerabilities in PEComa.  \nPerivascular epithelioid cell neoplasms (PEComas) are ultra-rare mesenchymal tumors that co-express smooth muscle and melanocytic markers1–8. PEComas predominantly arise sporadically, with an estimated incidence of 0.2 per million population per year, and can develop in virtually any anatomical location9,10. They occur more frequently in women, with a 6:1 female to male ratio and a median age at  \ndiagnosis ranging from 43–67 years11–13. Clinically, PEComas display a wide spectrum of behavior, ranging from indolent lesions to aggressive metastatic disease, with a reported 5-year event-free survival of approximately 58%14. To assist in prognostic stratiﬁcation, a histological classiﬁcation based on six tumor characteristics, known as the Folpe criteria, was proposed in 200511. More recently, we developed the PEC-  \nA full list of afﬁliations appears at the end of the paper. [e-mail:](e-mail: justine.gantzer@chru-strasbourg.fr)[ justine.gantzer@chru-strasbourg.fr](e-mail: justine.gantzer@chru-strasbourg.fr); [maloufg@igbmc.fr](maloufg@igbmc.fr)  \nPRO score, a prognostic tool designed to estimate the risk of postoperative recurrence—including both local relapse and distant metastasis—in patients with localized PEComa, based on clinicopathologic variables such as necrosis, vascular invasion, margin status and sex14.  \nCurrently, the systemic treatment of advanced PEComas primarily relies on mTOR inhibitors, which yield a median progression-free survival (PFS) of approximately 10 months13,15–18. This therapeutic strategy in PEComas is grounded in the frequent activation of themTOR signaling pathway, driven by recurrent molecular alterations. These include bi-allelic inactivation of TSC1 and TSC2—observed in approximately 10–20% and 30–40% o","cbCaisZFW0WgAKaM","https://ap.wps.com/l/cbCaisZFW0WgAKaM","pdf",8229280,24,"English","# Overview and clinical challenge\n## Multi-omic profiling strategy and main discoveries\n## Anatomical patterns of pathway alterations\n## Transcriptomic subtypes and lineage programs\n## Aggressive stem-like subtype and therapeutic vulnerabilities\n## Single-nucleus heterogeneity insights\n## Context: mTOR inhibitors and known genetic drivers","[{\"question\":\"What molecular alterations are frequently observed involving MITF in PEComa?\",\"answer\":\"The study identifies frequent MITF rearrangements involving actin gene partners such as ACTA2, ACTG1, and ACTB.\"},{\"question\":\"How do tumor subtypes and lineage programs relate to PEComa behavior?\",\"answer\":\"Transcriptomic analysis defines four subtypes with distinct lineage programs (melanocytic, mesenchymal, adipogenic), each with unique mutational patterns and clinical behaviors.\"},{\"question\":\"What characterizes the aggressive stem-like subtype and its treatment implications?\",\"answer\":\"The aggressive stem-like subtype is enriched for TP53/RB1 mutations, shows high proliferation and embryonic/Hedgehog activation, immune infiltration, and resistance to mTOR inhibitors, with potential responsiveness to immunotherapy.\"}]","MiT fusions, TSC1-TSC2 divergence, and stem-like programs reveal distinct originsand vulnerabilities in PEComa - Article | PDF",1790143230,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8c3310d00fac73a0938f2465d904e6f3.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fdbd9841ee8149c07b55a76d02deaac7.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/40a09159b706b1d2a4d157f203501939.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6421cf683173bdf526f7485789bd796f.webp",980,1301]